UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000025473
Receipt number R000028899
Scientific Title Phase II study of VI (vincristine, irinotecan) / VPC (vincristine, pirarubicin, cyclophosphamide) / IE (ifosfamide, etoposide) / VAC (vincristine, actinomycin D, cyclophosphamide) for patients with newly diagnosed high-risk rhabdomyosarcoma.
Date of disclosure of the study information 2017/02/01
Last modified on 2023/07/05 15:36:14

No. Disposal Last modified on Item of update
1 Insert 2016/12/29 12:48:32
2 Update 2019/07/12 18:17:35 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
3 Update 2019/07/12 18:20:19 Last follow-up date
4 Update 2021/07/03 11:01:12 Last follow-up date
5 Update 2023/07/05 15:36:14 Recruitment status
Date of IRB